Tin tức & Cập nhật

Male sex, elevated C-reactive protein (CRP), lower number of previous biologic/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) used, and lower Health Assessment Questionnaire (HAQ) score are all predictive of treatment response in European patients with psoriatic arthritis (PsA) treated with secukinumab, a study has shown.

Results from a subanalysis of the MAPLE-HCM* trial presented at ESC 2026 continue to support the superiority of aficamten over metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) irrespective of beta-blocker (BB) use at screening and prior standard-of-care (SoC) status.

In the phase IV VICTORION-Challenge trial, inclisiran outperforms bempedoic acid (BPA) for lowering LDL-C in individuals with high and very high cardiovascular (CV) risk.